STERRX, LLC is an FDA-Registered 503B Outsourcing Facility that was founded in 2013 as a manufacturer of sterile liquid pharmaceuticals. The company has a unique approach to 503B manufacturing by implementing robotic automation to minimize human contact in the manufacturing and packaging processes. This approach stems from the expertise of the SterRx founders in aseptic packaging of pharmaceuticals and medical devices, where cGMP has always been the standard.
The company currently has 100+ employees, including pharmacists, quality operators, compound staff, process engineers, and validation staff. Based in Plattsburgh, New York, SterRx operates in a production facility spanning over 50,000 square feet and with a production capacity of approximately 90-100 million units annually. The manufacturing operations are carried out via four fully enclosed blow-fill-seal (BFS) machines, which eliminate manual intervention, significantly reducing the risk of contamination and error.
SterRx secured a $15.00M Venture Round investment on 21 September 2017.
